Clinical Trials

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07524530 2026-04-22

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

98 enrolled

Leukemia, Lymphoma, Hematologic Neoplasms

NCT07527325 2026-04-22

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

35 enrolled

Dermatologic

Melanoma

NCT07528417 2026-04-22

MYELO-CAN:ABX

MyeloidOther hematologic neoplasm

75 enrolled

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

NCT07543783 2026-04-22

Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by TACE-HAIC

38 enrolled

Carcinoma, Hepatocellular

NCT07543848 2026-04-22

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

20 enrolled

Rectal Neoplasms

NCT07545044 2026-04-22

A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast Cancer

60 enrolled

Breast Neoplasms

NCT07545083 2026-04-22

Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC)

26 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07545213 2026-04-22

Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07545746 2026-04-22

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

140 enrolled

Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07158489 2026-04-21

ORIGIN2

47 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07379398 2026-04-21

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

28 enrolled

NSCLC

NCT07541430 2026-04-21

A Study in Adults With Desmoid Tumors

50 enrolled

Sarcoma

Desmoid Tumors

NCT07543172 2026-04-21

CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer

29 enrolled

Lung Neoplasms

NCT03301805 2026-04-20

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

40 enrolled

Pancreatic Neoplasms

NCT07015853 2026-04-20

ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

34 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07169617 2026-04-20

Testing the SurVaxM Vaccine for Lung Cancer Prevention

80 enrolled

Lung Neoplasms

NCT07194980 2026-04-20

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

20 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07538258 2026-04-20

Aurora004

27 enrolled

Small Cell Lung Carcinoma

NCT07538271 2026-04-20

Aurora 005

33 enrolled

Small Cell Lung Carcinoma

NCT07538401 2026-04-20

ASCiminib, With or Without Dasatinib Combination, as a 2nd-Line Therapy to ADVANCE the Treatment for Chronic Myelogenous Leukemia in Chronic Phase (ASC2ADVANCE)

MyeloidOther hematologic neoplasm

45 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT07539311 2026-04-20

RAINFOL-09

160 enrolled

Gastrointestinal Neoplasms

NCT07539753 2026-04-20

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

46 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT07540650 2026-04-20

pRevenT

90 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06855225 2026-04-17

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

29 enrolled

Liver Neoplasms

NCT07287098 2026-04-17

preEMBER

600 enrolled

Breast Neoplasms

NCT07387198 2026-04-17

NeoMatryx

135 enrolled

Dermatologic

Skin Neoplasms, Carcinoma, Merkel Cell

NCT07453095 2026-04-17

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

41 enrolled

Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT07527806 2026-04-17

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

156 enrolled

Breast Neoplasms

NCT07535632 2026-04-17

BEST

58 enrolled

Colorectal Neoplasms

NCT07535762 2026-04-17

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

36 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT07535905 2026-04-17

REVIVE

96 enrolled

Genitourinary

Hypogonadism, Prostatic Neoplasms

NCT07537400 2026-04-17

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

10 enrolled

CNS

Neuroblastoma

NCT07537777 2026-04-17

Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy

29 enrolled

Carcinoma, Hepatocellular

NCT07537972 2026-04-17

Denosumab Strategy for Liver Cancer With Bone Metastases

50 enrolled

Carcinoma, Hepatocellular

NCT07349771 2026-04-16

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

72 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

120 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07470489 2026-04-16

Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer

12 enrolled

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT07533227 2026-04-16

FMT-CACH

66 enrolled

Cachexia, Neoplasms

NCT07533942 2026-04-16

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

30 enrolled

CNS

Meningioma

NCT07172256 2026-04-15

CUE-101with Pembrolizumab for LA-HPV+HNSCCs

30 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07192237 2026-04-15

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

40 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07524894 2026-04-15

SNIFF

126 enrolled

Head and Neck Neoplasms

NCT07530224 2026-04-15

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

35 enrolled

Immune Checkpoint Inhibitor-Induced Dermatitis

NCT07530549 2026-04-15

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

40 enrolled

Esophageal Neoplasms

NCT07450599 2026-04-14

CHINANEO

250 enrolled

Genitourinary

High-Risk Localized Prostate Cancer

NCT07527169 2026-04-14

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

16 enrolled

CNS

Esthesioneuroblastoma, Olfactory

NCT07527520 2026-04-14

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

165 enrolled

Rectal Neoplasms

NCT07527858 2026-04-14

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

170 enrolled